Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03640325 · ClinicalTrials.gov registry record · NA
The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT03640325 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 143 participants.
The verdict
NCT03640325, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.
Interventions
- BEHAVIORAL PRISM (Promoting Resilience in Stress Management)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03640325
The ClinicalTrials.gov registry entry for NCT03640325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRISM (Promoting Resilience in Stress Management) is the first listed.
NCT03640325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03640325 about?
NCT03640325 is a clinical study titled "The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation". Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.
What is the current status of trial NCT03640325?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2019-04-01. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT03640325?
The interventions under investigation include: PRISM (Promoting Resilience in Stress Management) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03640325?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.